Valuation: ResMed, Inc.

Market Cap 27.84B 24.34B 22.45B 20.64B 39.11B 2,679B 39.78B 268B 105B 1,309B 105B 102B 4,513B P/E 2026 *
18.2x
P/E 2027 * 16.3x
Enterprise Value 27.04B 23.64B 21.81B 20.04B 37.98B 2,601B 38.63B 260B 102B 1,272B 102B 99.31B 4,383B EV / Sales 2026 *
4.78x
EV / Sales 2027 * 4.36x
Free-Float
75.61%
Yield 2026 *
1.26%
Yield 2027 * 1.36%
1 day+2.80%
1 week-3.42%
Current month+2.01%
1 month+3.14%
3 months-13.12%
6 months-23.75%
Current year-17.47%
1 week 190.25
Extreme 190.25
209.36
1 month 184.65
Extreme 184.65
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.80%-3.42%-21.12%-9.96% 27.84B
+0.76%+5.41%+28.65%+2.37% 198B
+2.63%-5.87%-23.72%+10.43% 134B
+1.25%+5.61%+4.47%-15.26% 141B
+1.29%-3.67%-58.29%-17.95% 63.36B
-2.33%-5.98%+14.63%-4.97% 51.87B
+1.34%+1.46%-24.75%-32.52% 43.77B
+0.40%+4.59%+19.52%+14.16% 38.18B
+0.09%+2.36%+30.13%+39.64% 36.96B
+2.90%-2.36%-15.10%-22.21% 28.05B
Average +1.07%-3.38%-4.56%-3.63% 76.38B
Weighted average by Cap. +1.13%-2.40%-0.06%-2.61%

Financials

2026 *2027 *
Net sales 5.65B 4.94B 4.56B 4.19B 7.94B 544B 8.07B 54.4B 21.35B 266B 21.22B 20.75B 916B 6.07B 5.31B 4.9B 4.5B 8.53B 584B 8.67B 58.44B 22.93B 285B 22.79B 22.29B 984B
Net income 1.55B 1.35B 1.25B 1.15B 2.17B 149B 2.21B 14.9B 5.85B 72.8B 5.81B 5.69B 251B 1.71B 1.49B 1.38B 1.27B 2.4B 164B 2.44B 16.44B 6.45B 80.3B 6.41B 6.27B 277B
Net Debt -804M -703M -648M -596M -1.13B -77.35B -1.15B -7.74B -3.04B -37.81B -3.02B -2.95B -130B -1.36B -1.19B -1.1B -1.01B -1.91B -131B -1.94B -13.1B -5.14B -63.98B -5.11B -5B -221B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
16/07/26 USD 198.69 +2.94% 543,429
14/07/26 USD 193.01 -2.77% 1,622,359
13/07/26 USD 198.50 -2.63% 2,161,420
10/07/26 USD 203.87 -2.20% 1,331,149
09/07/26 USD 208.45 +1.27% 1,479,036
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
193.01USD
Average target price
253.20USD
Spread / Average Target
+31.18%

Quarterly revenue - Rate of surprise